INK 128 (MLN0128)
分子式：C15H15N7O
分子量：309.33
产品描述
INK 128是有效的，选择性mTORYZ剂，IC50为1 nM;对I型PI3K亚型的作用效果低200倍以上,与Rapamycin相比，优先YZmTORC1/2，且对促侵袭基因敏感。
靶点
mTOR IC501 nM
体外研究
INK 128 exhibits an enzymatic inhibition activity against mTOR and more than 100-fold selectivity to PI3K kinases.As TORC1/2 inhibitor, INK 128 inhibits both the phosphorylation of S6 and 4EBP1, the downstream substrates of TORC1, and selectively inhibits AKT phosphorylation at Ser473, the downstream substrate of TORC2. Furthermore, INK 128 also shows potent inhibition effects on cell lines resistant to rapamycin and pan-PI3K inhibitors.
体内研究
In a ZR-75-1 breast cancer xenograft model, INK 128 shows tumor growth inhibition efficacy at a dose of 0.3 mg/kg/day.Daily, oral administration of INK 128 inhibits angiogenesis and tumor growth in multiplexenograft models.溶解性DMSO 62 mg/mL，水 <1 mg/mL，乙醇 2 mg/mL
稳定性
2年 -20°C粉状，6月-80°C溶于DMSO
温馨提示：不可用于临床ZL。
